DL
AGN

Daniel Loeb’s Allergan plc AGN Stock Holding History

Daniel Loeb’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-500,000
Closed -$116M – 45
2016
Q2 		$116M Buy
+500,000
New +$115M 1.1% 25
2014
Q1 		– Sell
-15,000
Closed -$2.52M – 59
2013
Q4 		$2.52M Buy
+15,000
New +$2.34M 0.04% 43

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Daniel Loeb's AGN Position: Q2 2020 in Review

Daniel Loeb sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,311,500 shares — an estimated $764M sold.

Daniel Loeb first reported a position in AGN in Q1 2014 and held it in 14 quarters. The position peaked at $1.69B in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Daniel Loeb reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Daniel Loeb sold 4,311,500 Allergan plc shares in Q2 2020, an estimated $764M.
  • Daniel Loeb first reported a position in Allergan plc in Q1 2014 and held it in 14 quarters.
  • Daniel Loeb's Allergan plc position peaked at $1.69B in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Third Point's 13F filing for Q2 2020, filed 17 Aug 2020.